As of 2026-03-24, the Intrinsic Value of CareDx Inc (CDNA) is 3.78 USD. This CareDx valuation is based on the model Discounted Cash Flows (EBITDA Exit 10Y). With the current market price of 17.56 USD, the upside of CareDx Inc is -78.50%.
The range of the Intrinsic Value is 0.13 - 10.45 USD
Based on its market price of 17.56 USD and our intrinsic valuation, CareDx Inc (CDNA) is overvalued by 78.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (63.55) - (13.43) | (21.81) | -224.2% |
| DCF (Growth 10y) | (8.30) - (32.30) | (12.34) | -170.3% |
| DCF (EBITDA 5y) | (1.06) - 1.46 | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | 0.13 - 10.45 | 3.78 | -78.5% |
| Fair Value | -2.08 - -2.08 | -2.08 | -111.87% |
| P/E | (8.36) - (10.92) | (9.07) | -151.6% |
| EV/EBITDA | 0.15 - (2.08) | (0.81) | -104.6% |
| EPV | (15.66) - (18.80) | (17.23) | -198.1% |
| DDM - Stable | (5.10) - (23.94) | (14.52) | -182.7% |
| DDM - Multi | 0.75 - 2.82 | 1.20 | -93.2% |
| Market Cap (mil) | 899.42 |
| Beta | 0.66 |
| Outstanding shares (mil) | 51.22 |
| Enterprise Value (mil) | 833.99 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.64% |
| Cost of Debt | 5.00% |
| WACC | 6.30% |